1. Lei Xiong, Jianshang Huang, Yunsheng Dong, Suthat Liangpunsakul , Feng Cao,Honglei Weng,Bei Tan, Jerrold R Turner , Hua Wang , Li Zuo.Targeting MLCK1 uncouples immune checkpoint inhibitor-induced colitis from antitumour immunity.Gut.2026;0:1-13.(IF:26.2)
2. Zuo L#*, Kuo WT#, Cao F, Chanez-Paredes SD, ZeveD, Mannam P, Jean-François L, Day A, Graham W V, Sweat YY.ShashikanthN, BreaultDT, and Turner JR*. The tacrolimus-binding protein FKBP8 directs myosin light chainkinase-dependent barrier regulation and is a potential therapeutictarget in Crohn’s disease. Gut.2023;72(5):870-881(Co-Corresponding author) (IF:31.793)
3. Kuo WT#; Zuo L#; Odenwald MA; MadhaS; Singh G;GurniakCB.; Abraham C; Turner JR*. The Tight Junction ProteinZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair, Gastroenterology, 2021, 161(6):1924-1939. (Co-first author) (IF:32.8)
4. An, C., Jiang, C., Pei, W., Li, A., Wang, M., Wang, Y., Wang, H., & Zuo, L. (2025). Intestinal epithelial cells in health and disease. Tissue barriers,Advance online publication. 2025.25047449(IF: 4.0)
5. Yunsheng Dong，Lei Xiong，Nina Zhu，Li Zuo*，Hua Wang*，Extracellular Vesicles in Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities，iNew Medicine
2025; 1:e3( IF:3 )
6. Zihan Wang , Zixuan Cao, Yunsheng Dong, Yi Hong, Li Zuo, Hua Wang. Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications. Hepatol Commun. 2026；0:1-21.(IF:4.60)
7. Zhang M, Ji J, Song J, Li Zuo*, Hua Wang*.Current Therapeutic Targets for Alcohol-Associated Liver Disease. Am J Pathol. Published online July 17, 2025. doi:10.1016/j.ajpath.2025.06.009(IF:3.6)
8. Cheng Q, Wu M, Wei X, Lu L, Liu R, Li Y, Zhu N, Li Y, Zuo L, Wang H. Hepatocyte cellular repressor of E1A-stimulated genes 1 protects against acetaminophen-induced liver injury by promoting autophagy. Acta Pharmacologica Sinica.2025 Aug;46(8):2237-2250. (IF:6.9)
9. Sainan Tang#, Shanshan Wu, Wenzhe Zhang, Lili Ma, Li Zuo*, Hua Wang*.Immunology and treatments of fatty liver disease.Archives of Toxicology (2025) 99:127–152(IF:4.8)
10. Wu S, Gao J, Han Y, Zhang W, Li X, Kong D, Hua W, Zuo L. Balancing act: The dual role of claudin-2 in disease. Ann. N. Y. Acad. Sci. 2025 Apr;1546(1):75-89. (IF: 4.1)
11. Xiong, Lei, Jiangshang Huang, Shabnam Abtahi, Jerrold Turner, Wei-Ting Kuo, Hua Wang and Li Zuo. “108 TIGHT JUNCTION PLAYS AN ESSENTIAL ROLE IN IMMUNOTHERAPYINDUCED COLITIS AND TUMOR PROGRESSION.” Gastroenterology (2024):n. pag.
12. Huang J, Xiong L, Tang S, Zhao J, Zuo L*. Balancing Tumor Immunotherapy and Immune- Related Adverse Events: Unveiling the Key Regulators. Int J Mol Sci. 2024 Oct 10;25(20):10919.（IF:4.9）
13. Wenjia Lu#, Chonggui Jiang, Yajie Chen, Zhonghua Lu, Xueli Xu, Liting Zhu, Haotong Xi, Guozhu Ye, Changzhou Yan, Jinsheng Chen, Jie Zhang*, Li Zuo*, QianshengHuang*. Altered metabolome and microbiome associated with compromised intestinal barrier induced hepatic lipid metabolic disorder in mice after subacute and subchronic ozone exposure. Environ Int. 2024 Mar:185:108559. (Q1; IF:11.8)
14. Wang J#, Wang X, Peng H, Dong Z, Liangpunsakul S, Zuo L*, Wang H*. Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils. Cell Mol Gastroenterol Hepatol. 2024;18(1):41-52. (IF:7.9)
15. Xianda Wang#, Juan Wang#, Haodong Peng#, Li Zuo*, Hua Wang*. Role of immune cell interactions in alcohol-associated liver diseases. Liver Res. 2024; 8(2):72-82.
16. Chanez-Paredes, S. D., Abtahi, S., Zha, J., Li, E., Marsischky, G., Zuo, L., Grey, M. J., He, W., & Turner, J. R. (2024). Mechanisms underlying distinct subcellular localization and regulation of epithelial long myosin light-chain kinase splice variants. The Journal of biological chemistry, 300(2), 105643. (IF:4)
17. Li, G., Gao, M., Zhang, S., Dai, T., Wang, F., Geng, J., Rao, J., Qin, X., Qian, J., Zuo, L., Zhou, M., Liu, L., & Zhou, H. (2024). Sleep Deprivation Impairs Intestinal Mucosal Barrier by Activating Endoplasmic Reticulum Stress in Goblet Cells. The American journal of pathology, 194(1), 85–100. (IF:5.77)
18. Zhu, L., Xiong, L., Huang, J., Jiang, C., Xu, W., Zhang, J., Hu, C., Zhong, Y., Dong, Z., Chen, F., Zhu, H., Kuo, W. T., Cao, F., & Zuo, L. (2023). A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells. Heliyon, 9(11), e21664. (IF:4)
19. Kuo WT#; Odenwald MA; Turner JR*, Zuo L*. Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival. Ann NY Acad Sci. 2022 Aug;1514(1):21-33. (IF:5.691)
20. Zuo L#, Kuo WT# and Turner JR*. Tight junctions as targets and effectors of mucosal immune homeostasis. Cellular and Molecular Gastroenterology and Hepatology. 2020;10(2):327-340. (IF:8.797)
21. Feng Cao#; Le Zhu#; Jing Zhang; PawinPongkorpsakol; Wei-Ting Kuo; Jerrold R. Turner; Qing Zhou; Yuan Wang; Feihu Chen; Yehai Liu*; Li Zuo*; Myosin light chainkinase is a potential target for hypopharyngeal cancer treatment, Biomedicine &Pharmacotherapy, 2020, 131:110665. (IF:6.529)
22. Nalle SC#, Zuo L, Ong MLDM, Singh, Worthylake A, Choi WS, Manresa MC, Southworth A, Edelblum KL, Baker GJ, Joseph NE, Savage PA and Turner JR*. Graft-versus-host-disease propagation depends on increased intestinal epithelial tight junction permeability. The Journal of Clinical Investigation. 2019,129(2): 902-914. (IF:19.456)
23. Kuo WT#, Shen L#, Zuo L, Nitesh S, Ong MLDM, Wu LC, Zha JM, Edelblum KL, Wang YT, Wang YM, Nilsen SP, Turner JR*. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression. Gastroenterology, 2019, 157(5): 1323-1337(IF:32.8)
24. Pawin Pongkorpsakol#, Jerrold R Turner*, Li Zuo*. Culture of Intestinal Epithelial Cell Monolayers and Their Use in Multiplex Macromolecular Permeability Assays for In Vitro Analysis of Tight Junction Size Selectivity. Curr Protoc Immunol. 2020 Dec;131(1):e112. (IF:2.911)
25. Srivastava AK#, Venkata BS, Sweat YY, Rizzo HR, François LJ, Zuo L, Kurgan KW, Moore P, Shashikanth N, Smok L, Sachleben JR, Turner JR, Meredith SC. Serine 408 phosphorylation is a molecular switch that regulates structure and function of the occludin a-helical bundle. Proc. Natl. Acad. Sci. 2022; 119(34):e2204618119. (IF;11.205)
26. Yang XP#, Zou DB, Tang ST, FanT, Su H, Hu R, Zhou Q, Gui S, Zuo L*,Wang Y*. Ameliorative effect of melatonin against increased intestinal permeability in diabetic rats:possible involvement of MLCK dependent MLC phosphorylation. Mol Cell Biochem.2016;416(1-2):23-2.（Co-Corresponding Author）(IF:3.842)
27. Zuo L#,Yang X, Lu M, Hu R, Zhu H, Zhang S, Zhou Q, Chen F, Gui S, Wang Y. All Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Down regulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway. Nutr Cancer. 2016;68(7):1225-33. (IF:2.816)
28. Zuo L#, Zhang SM#, Hu RL, Zhu HQ, Zhou Q, Gui SY, Wu Q, Wang Y. Correlation between expression and differentiation of Endocan in colorectalcancer. World J Gastroenterol.2008;14(28):4562-8. (IF:5.374)
29. Zuo L#, Lu M#, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating Endocan expression by MAPK signaling pathway. Food Chem Toxicol.2013;62:892-900 (IF:5.572)
30. Zhang SM#, Zuo L#, Gui SY, Zhou Q, Wei W, Wang Y. Induction of cell differentiation and promotion of Endocan gene expression in stomach cancer by melatonin. Mol Biol Rep. 2012;39:2843-2849.(Co-first Author) (IF:2.742)
